Scientist I, Clinical Biomarker Development (Cancer Genomics)

Revolution Medicines is a clinical-stage precision oncology company seeking a Scientist I in Clinical Biomarker Development to develop biomarker, technology, and computational strategies for RAS(ON) inhibitor programs.

Requirements

• Ph.D. in Cancer Genomics, Genetics, Computational Biology, or similar degree
• Proficiency in programming languages R and/or Python
• Expertise in genomics data analysis, Linux, and cloud computing
• Experience with genomics workflows, RNAseq data, and DNA sequence data
• Strong communication and interpersonal skills

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits
• Significant learning and development opportunities